After Chevron: FDA Overreach May Find Itself In Crosshairs
By Maura Monaghan, Paul D. Rubin and Jacob Stahl · July 8, 2024, 7:01 PM EDT
On June 28, the U.S. Supreme Court overturned a decades-old precedent, known as Chevron deference, that favored federal agencies' rulemaking interpretations. In this Expert Analysis series, attorneys discuss the decision's likely impact...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login